Nutritional supplementation and length of stay: a controlled trial of nutritional supplementation in a mixed acute hospital setting

ISRCTN ISRCTN78277754
DOI https://doi.org/10.1186/ISRCTN78277754
Secondary identifying numbers RDC00898
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
11/01/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Jeremy Powell-Tuck
Scientific

St Bartholomew's & Royal London School of Medicine & Dentistry
Department of Human Nutrition
Royal London Hospital
Whitechapel
London
E1 1BB
United Kingdom

Phone +44 (0)20 7377 7000 ext 2664

Study information

Study designRandomised placebo controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeOther
Scientific title
Study objectivesLoss of weight and low body weight expressed as a function of height are both common among patients admitted to hospital. A pilot study has shown that about 30% of patients admitted as emergencies to the Royal London Hospital have biochemically demonstrable B vitamin deficiencies. Several studies have demonstrated the relationship between length of hospital stay, morbidity, mortality and such indices of nutritional status, but it is unclear to what extent this relationship is causal. The principal purpose of this study is to examine the effect of two strategic nutritional interventions in a large number of non-elective admissions to the Royal London Hospital on length of stay and mortality. We propose a randomized placebo controlled trial of early dietary supplementation with a palatable liquid oral sip feed and/or water soluble vitamins. In this study we have the opportunity further to document nutritional status among such patients and to develop techniques for rapid determination of water soluble vitamin status.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedOther symptoms and general pathology
Intervention1. Palatable liquid oral sip feed with vitamin supplements
2. Placebo (palatable liquid oral sip feed only)
Intervention typeOther
Primary outcome measure1. It is expected that a significant incidence of biochemical water soluble vitamin deficiency will be detected among the patients admitted via accident and emergency and that HPLC of single blood samples, will provide a reliable method for assay, and prove much more rapid and convenient than the established enzymatic methods of routine screening.
2. The incident of protein/energy malnutrition detected by anthropometric assessment is expected to approximate 40% in the study group of patients.
3. Previous studies suggest that we might expect a reduction of length of stay as a result of feed supplementation of undernourished inpatients. We might also see reductions in mortality in this group.
4. We might detect a reduction in length of stay and mortality as a result of water soluble vitamin supplementation, either in the study population as a whole, or within subgroups identified in the course of the study.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/09/1997
Completion date01/09/1999

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participantsNot provided at time of registration
Key inclusion criteria1. Patients admitted acutely to general medicine, general surgery and orthopaedics.
2. Patients with a body mass index <22 within the above sample, will be randomized to oral sipfeed or placebo feed, independent of whether they are receiving vitamin supplements.
Key exclusion criteria1. Planned admission to medical or orthopaedic wards or to wards other than those 15 taking part in the study.
2. Less than 18 years
3. Mental illness
4. Admission for only 2 days
Date of first enrolment01/09/1997
Date of final enrolment01/09/1999

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

St Bartholomew's & Royal London School of Medicine & Dentistry
London
E1 1BB
United Kingdom

Sponsor information

NHS R&D Regional Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Executive London (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2001 Yes No